James L. Schaller, M.D.  •  239-263-0133


Persistent Lyme Disease Information Resources

Of course, the best evidence of failure with the 30, 240-minute (3 week) approach to Lyme treatment is that it assumes ticks only carry one infection. What a sad belief. The other issue is other health care workers are left to "clean up" this magical machine view of the body, and these massively complex infections after 30, 240-minutes of treatment fails—in a month, week, season, year or decade. Patients reject and leave the 3 week folks and go to others who have ears to listen and do not insult them. Some of these patients are far smarter, with higher IQs, than their physicians.

  1. [PDF] Relapse/Persistence of Lyme Disease Despite Antibiotic Therapy
  2. [PDF] Lyme Disease: Survival in Adverse Conditions
  3. A proposal for the reliable culture of Borrelia burgdorferi from patients with chronic Lyme disease, even from those previously aggressively treated
  4. Borrelia burgdorferi detected by culture and PCR in clinical relapse of disseminated Lyme borreliosis
  5. Borrelia burgdorferi myositis: report of eight patients
  6. Chronic neurologic manifestations of Lyme disease
  7. Chronic septic arthritis caused by Borreliaburgdorferi
  8. Clinical implications of delayed growth of the Lyme borreliosis spirochete, Borrelia burgdorferi
  9. Clinical manifestations, pathogenesis, and effect of antibiotic treatment on Lyme borreliosis in dogs.
  10. Detection of Borrelia burgdorferi Antigen in Urine from Patients with Lyme Borreliosis
  11. Detection of Borrelia burgdorferi antigens in cerebrospinal fluid
  12. Detection of Borrelia burgdorferi by polymerase chain reaction in synovial membrane, but not in synovial fluid from patients with persisting Lyme arthritis after antibiotic therapy
  13. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis
  14. Diagnostic Hints and Treatment Guidelines for Lyme and Other Tick Borne Illnesses
  15. Electron microscopy and the polymerase chain reaction of spirochetes from the blood of patients with Lyme disease
  16. Evidence-based guidelines for the management of Lyme disease
  17. Experimental Lyme disease in dogs produces arthritis and persistent infection
  18. Fatal encephalitis caused by concomitant infection with tick-borne encephalitis virus and Borrelia burgdorferi
  19. Fibroblasts protect the Lyme Disease spirochete, Borrelia burgdorferi from ceftriaxone in vitro
  20. First isolation of Borrelia burgdorferi from an iris biopsy
  21. Formation and Cultivation of Borrelia burgdorferi Spheroblast-L Form Variants
  22. Inflammatory brain changes in Lyme borreliosis
  23. Intracellular localization of Borrelia burgdorferi within human endothelial cells
  24. Invasion of human neuronal and glial cells by an infectious strain of Borrelia burgdorferi.
  25. Invasion of human skin fibroblasts by the Lyme disease spirochete, Borrelia burgdorferi
  26. Isolation of Borrelia burgdorferi from the myocardium of a patient with longstanding cardiomyopathy
  27. Isolation of Borrelia burgdorferi in the cerebrospinal fluid of 3 children with neurological involvement
  28. Kill kinetics of Borrelia burgdorferi and bacterial findings in relation to the treatment of Lyme borreliosis
  29. Latent Lyme neuroborreliosis: presence of Borrelia burgdorferi in the cerebrospinal fluid without concurrent inflammatory signs
  30. Localization of Borrelia burgdorferi in the nervous system and other organs in a nonhuman primate model of Lyme disease
  31. Lyme arthritis in a 12-year-old patient after a latency period of 5 years
  32. Lyme borreliosis--a review of the late stages and treatment of four cases
  33. Lyme Disease: An Infectious and Postinfectious Syndrome
  34. Lyme disease: point/counterpoint.
  35. Lyme disease: The sensible pursuit of answers
  36. Lyme meningoencephalitis: report of a severe, penicillin-resistant case.
  37. Molecular detection of persistent Borrelia burgdorferi in a man with dermatomyositis
  38. Neuroborreliosis in the nonhuman primate: Borrelia burgdorferi persists in the central nervous system
  39. Pars plana vitrectomy in Borrelia burgdorferi endophthalmitis
  40. Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment
  41. Persistence of Borrelia burgdorferi sensu lato in patients with Lyme borreliosis
  42. Persistence of Borrelia burgdorferi sensu lato in resolved erythema migrans lesions.
  43. Persistence of Borrelia garinii and Borrelia afzelii in patients with Lyme arthritis
  44. Persistence of Organisms for Lyme Arthritis
  45. Persistent PCR Positivity in a patient being treated for Lyme disease
  46. Physician Preferences in the Diagnosis and Treatment of Lyme Disease in the United States
  47. Pulsed high-dose cefotaxime therapy in refractory Lyme Borreliosis
  48. Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis
  49. Recurrent and relapsing borreliosis of the nervous system
  50. Recurrent erythema migrans despite extended antibiotic treatment with minocycline in a patient with persisting Borrelia burgdorferi infection
  51. Seronegative Chronic Relapsing Neuroborreliosis
  52. Spirochetes in the spleen of a patient with chronic Lyme disease
  53. Subacute multiple-site osteomyelitis caused by Borrelia burgdorferi
  54. Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis
  55. The fate of Borrelia burgdorferi in mouse macrophages: destruction, survival, recovery
  56. The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study
  57. The Lyme Wars: time to listen
  58. The persistence of spirochetal nucleic acids in active Lyme arthritis
  59. The western immunoblot for Lyme disease: determination of sensitivity, specificity, and interpretive criteria with use of commercially available performance panels
  60. Treatment of refractory chronic Lyme arthritis with arthroscopic synovectomy
LYME DISEASE BABESIA BARTONELLA BEST DOCTORS 26 BOOKS/27 PAPERS  TREATMENT ILADS IGENEX MOLD ILLNESS BIOTOXINS JAMES SCHALLER